Compounds > canertinib
Page last updated: 2024-09-04

canertinib and bisindolylmaleimide iv

canertinib has been researched along with bisindolylmaleimide iv in 1 studies

Compound Research Comparison

Studies
(canertinib)		Trials
(canertinib)		Recent Studies (post-2010)
(canertinib)		Studies
(bisindolylmaleimide iv)		Trials
(bisindolylmaleimide iv)		Recent Studies (post-2010) (bisindolylmaleimide iv)
1249651704

Protein Interaction Comparison

ProteinTaxonomycanertinib (IC50)bisindolylmaleimide iv (IC50)
Serine/threonine-protein kinase D3Homo sapiens (human)0.19
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)2.955
Protein kinase C gamma typeHomo sapiens (human)0.19
Protein kinase C alpha typeRattus norvegicus (Norway rat)0.325
Protein kinase C beta typeHomo sapiens (human)0.1805
Protein kinase C delta typeRattus norvegicus (Norway rat)0.325
Protein kinase C epsilon typeRattus norvegicus (Norway rat)0.325
Protein kinase C zeta typeRattus norvegicus (Norway rat)0.325
Cyclin-dependent kinase 4Homo sapiens (human)5.81
Protein kinase C alpha typeHomo sapiens (human)0.8945
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoformOryctolagus cuniculus (rabbit)3.2
G1/S-specific cyclin-D1Homo sapiens (human)5.81
Protein kinase C eta typeHomo sapiens (human)0.19
G1/S-specific cyclin-E1Homo sapiens (human)5.81
Cyclin-dependent kinase 2Homo sapiens (human)5.81
cAMP-dependent protein kinase catalytic subunit alpha Rattus norvegicus (Norway rat)2.55
Protein kinase C iota typeHomo sapiens (human)0.19
Protein kinase C gamma typeRattus norvegicus (Norway rat)0.4
Protein kinase C beta typeRattus norvegicus (Norway rat)0.4
Protein kinase C epsilon typeHomo sapiens (human)3.853
Protein kinase C theta typeHomo sapiens (human)0.19
Protein kinase C zeta typeHomo sapiens (human)0.19
Protein kinase C delta typeHomo sapiens (human)0.19
Calcium/calmodulin-dependent protein kinase type II subunit deltaHomo sapiens (human)1.19
Serine/threonine-protein kinase D1Homo sapiens (human)0.19
Protein kinase C eta typeRattus norvegicus (Norway rat)0.325
NAD-dependent protein deacetylase sirtuin-2Homo sapiens (human)4.7
Protein kinase C theta typeRattus norvegicus (Norway rat)0.325

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bharate, SB; Raghuvanshi, R1

Other Studies

1 other study(ies) available for canertinib and bisindolylmaleimide iv

ArticleYear
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Throughput Screening Assays; Humans; Protein Kinase Inhibitors; SARS-CoV-2; United States; United States Food and Drug Administration; Virus Diseases

2022